跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levoxina - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levoxina
Approved
STANDARD
Levoxina
Eurolife Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a9877a0248b5e760
Company
Eurolife Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
a9877a0248b5e760
Drug Approval Philippines Name
Levoxina
Product Name
Levoxina
Registration Number
DRP-7920-01
Brand Name
Levoxina
Generic Name
Levofloxacin (as hemihydrate)
Dosage Form
Solution for IV Infusion
Dosage Strength
5 mg/mL (500 mg/100 mL)
Manufacturer
Eurolife Healthcare Pvt. Ltd.
Importer
Aglobal Care, Inc
Distributor
Jackson Pharmaceuticals Inc.
Issuance Date
26 October 2021
Expiry Date
25 July 2026
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a9877a0248b5e760
Type
Standard
Back to Philippines FDA Approvals